L Schrier1, K Illy2, A Valiulis3, C Wyder4, T Stiris5,6. 1. Department of Paediatrics, Willem Alexander Children's Hospital, Leiden University Medical Center, Leiden, The Netherlands. l.schrier@lumc.nl. 2. Department of Paediatrics, Rivierenland Hospital, Tiel, The Netherlands. 3. Vilnius University Clinic of Children's Diseases and Public Health Institute, Vilnius, Lithuania. 4. Paediatric Primary Care Center Kurwerk, Burgdorf, Switzerland. 5. Department of Neonatology, Oslo University Hospital, Oslo, Norway. 6. Faculty of Medicine, University of Oslo, Oslo, Norway.
Abstract
European children and paediatricians rely heavily on the fair, complete and timely publication of data obtained from paediatric randomised controlled trials (RCTs). Selective publication and reporting of paediatric RCTs is common practice. Industry-sponsored trials are more likely to remain unpublished, and take longer to get published compared with trials sponsored by others. However, also academic sponsors contribute to inefficiencies in publishing clinical data. Publication bias violates the ethical obligation that investigators have towards study participants, leads to considerable inefficiencies in research and a waste of financial and human resources, and has the potential to distort evidence for treatment approaches. CONCLUSION: The European Academy of Paediatrics (EAP) therefore actively supports initiatives that increase the public dissemination of paediatric clinical trial data. The EAP will raise awareness about the guidelines for Good Publication Practice among European paediatricians and subspecialty societies.
European children and paediatricians rely heavily on the fair, complete and timely publication of data obtained from paediatric randomised controlled trials (RCTs). Selective publication and reporting of paediatric RCTs is common practice. Industry-sponsored trials are more likely to remain unpublished, and take longer to get published compared with trials sponsored by others. However, also academic sponsors contribute to inefficiencies in publishing clinical data. Publication bias violates the ethical obligation that investigators have towards study participants, leads to considerable inefficiencies in research and a waste of financial and human resources, and has the potential to distort evidence for treatment approaches. CONCLUSION: The European Academy of Paediatrics (EAP) therefore actively supports initiatives that increase the public dissemination of paediatric clinical trial data. The EAP will raise awareness about the guidelines for Good Publication Practice among European paediatricians and subspecialty societies.
Authors: Wendy P Battisti; Elizabeth Wager; Lise Baltzer; Dan Bridges; Angela Cairns; Christopher I Carswell; Leslie Citrome; James A Gurr; LaVerne A Mooney; B Jane Moore; Teresa Peña; Carol H Sanes-Miller; Keith Veitch; Karen L Woolley; Yvonne E Yarker Journal: Ann Intern Med Date: 2015-09-15 Impact factor: 25.391
Authors: Lamberto Manzoli; Maria Elena Flacco; Maddalena D'Addario; Lorenzo Capasso; Corrado De Vito; Carolina Marzuillo; Paolo Villari; John P A Ioannidis Journal: BMJ Date: 2014-05-16
Authors: Michele P Hamm; Lisa Hartling; Andrea Milne; Lisa Tjosvold; Ben Vandermeer; Denise Thomson; Sarah Curtis; Terry P Klassen Journal: BMC Pediatr Date: 2010-12-22 Impact factor: 2.125
Authors: Tom Jefferson; Mark A Jones; Peter Doshi; Chris B Del Mar; Rokuro Hama; Matthew J Thompson; Elizabeth A Spencer; Igho Onakpoya; Kamal R Mahtani; David Nunan; Jeremy Howick; Carl J Heneghan Journal: Cochrane Database Syst Rev Date: 2014-04-10